DR.REDDY'S LABORATORIES LTD. - ZEMBRACE" SymTouch" (sumatriptan injection) 3 mg, approved by the FDA in January 2016 for the acute treatment of migraine with or without aura in adults, is now commercially available in the U.S.

Rediff Moneywiz

Hi Guest
Feedback

DR.REDDY'S LABORATORIES LTD. - ZEMBRACE" SymTouch" (sumatriptan injection) 3 mg, approved by the FDA in January 2016 for the acute treatment of migraine with or without aura in adults, is now commercially available in the U.S.

Download	< Back
19 Apr 2016
Dr Reddys Laboratories Ltd has informed BSE regarding a Press Release dated April 19, 2016 titled "ZEMBRACE" SymTouch" (sumatriptan injection) 3 mg, approved by the FDA in January 2016 for the acute treatment of migraine with or without aura in adults, is now commercially available in the U.S.".
View all announcements for DR.REDDY'S LABORATORIES LTD.	Source: BSE India

ALL MONEYWIZ PAGES